AUD meds still underused

- Commentary and a lecture highlighted persistent underuse of three FDA‑approved medications for alcohol use disorder across clinicians and systems. - The lecturer, Dr. Erik Messamore, reviewed barriers and clinical reasons for underuse in a recorded talk linked to practice education. - Increasing uptake of naltrexone, acamprosate and disulfiram requires clinician education and system supports to offer medication options consistently. (youtube.com)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.